Trellus Health PLC
LSE:TRLS
Relative Value
The Relative Value of one TRLS stock under the Base Case scenario is hidden GBX. Compared to the current market price of 0.525 GBX, Trellus Health PLC is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
TRLS Competitors Multiples
Trellus Health PLC Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| UK |
T
|
Trellus Health PLC
LSE:TRLS
|
948.9k GBP | 3.6 | -0.2 | 0 | 0 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
97B USD | 0.2 | 54.9 | 14 | 14 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
68.2B EUR | 0.3 | 13.3 | 7.8 | 9.9 | |
| US |
|
Cigna Corp
NYSE:CI
|
69.1B USD | 0.3 | 11.6 | 0 | 0 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
27.3B EUR | 1.2 | 21.6 | 10 | 14.9 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.9B EUR | 1.2 | 23.4 | 9 | 16.7 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
22.1B USD | 1.6 | 25.2 | 12.1 | 17.6 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
22.1B USD | 2 | 22.4 | 12.4 | 16.8 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.1B EUR | 0.6 | 11.3 | 5.4 | 10 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.8B USD | 12 | -28.4 | -30.5 | -27.7 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.4B USD | 0.8 | 13.9 | 7.3 | 9.9 |